Learn how to use Mayo Clinic Connect
Request an Appointment
Has anyone heard about the product that Windsantor is testing now for Neuropathy? I’m wondering if it is moving forward. I can’t find much information about it.
Interested in more discussions like this? Go to the Neuropathy group.
I have Peripheral Neuropathy that is becoming more debilitating. I need the BEST way to try to keep it from getting worse. I eat healthy and exercise 5 X a week for an hour. I live alone and worry how fast this progresses. I realize there is no cure, individualized, but what action is the most beneficial? Are there foods to avoid? Sleep is also a problem. I could use more solutions. Thank you.
Who makes it? Where is it being developed?
Jump to this post
Try deep tissue massage to get the blood flow into your feet. And stretching exercises to also promote blood flow, calf and hamstrings.
Avoid as much sugar as possible. For sleep aids maybe try Melatonin! About 10mg per night.
Mayo Clinic is great, thanks
Is it a drug, a medical device, a topical?
@julkin – WinSanTor is a company but the drug they make is what this discussion is about. Here's an article about it.
"Treating Peripheral Neuropathy
The hope is that these new findings support the potential for select anti-muscarinic drugs already on the market, like pirenzepine, to be repurposed as a possible preventative, and even treatment, for the clinical effects of peripheral neuropathy, which, for patients, has been largely been a matter of pain relief, and associated with significant health care costs." — Blocking Anti-Muscarinic Drugs May Reverse PN: https://winsantor.com/anti-muscarinic-drugs-may-reverse-peripheral-neuropathy/
WinSanTor’s lead compound, WST-057 is the topical containing pirenzepene – https://winsantor.com/pipeline/
More info on the Phase 2 clinical trial page – https://clinicaltrials.gov/ct2/show/NCT04005287
Is it now on the market?
I have researched it and it sounds very promising.
Not that I'm aware of…I thought the article mentioned 3 to 5 years out
"Our aim is to change the current state of neuropathy in three to five years by bringing to market hope for peripheral neuropathy sufferers. WinSanTor’s lead compound, WST-057, shows the ability to prevent nerve damage and re-grow damaged nerves. With its well-known safety profile, WST-057 is on track to an accelerated regulatory approval and to the clinic." — https://winsantor.com/pipeline/
Create an account to connect with other patients and caregivers like you.Ask questions, get answers, and give and get support.Also follow blogs from Mayo Clinic experts.
Already have an account? Sign In